Levine As

746 total citations
19 papers, 605 citations indexed

About

Levine As is a scholar working on Oncology, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Levine As has authored 19 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Animal Science and Zoology. Recurrent topics in Levine As's work include Sarcoma Diagnosis and Treatment (2 papers), Neutropenia and Cancer Infections (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Levine As is often cited by papers focused on Sarcoma Diagnosis and Treatment (2 papers), Neutropenia and Cancer Infections (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Levine As collaborates with scholars based in United States and Hungary. Levine As's co-authors include Young Rc, Graw Rg, Schimpff Sc, Roger Woodgate, B Lange, Richard L. Atkinson, Paul E. Gormley, Julie Kneip, Martha K. Grace and Von Hoff and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Levine As

17 papers receiving 472 citations

Peers

Levine As
Comparison fields: 5 of 85
  • Oncology 290
  • Epidemiology 134
  • Pulmonary and Respiratory Medicine 118
  • Molecular Biology 108
  • Infectious Diseases 81
Replace S. M. Wolff with:
S. M. Wolff United States
H. Sund Kristensen Denmark
William C. Cooper United States
James K. Kelly Canada
Víctor Toledano Spain
Paul V. Thomas United States
S T Pottratz United States
Jürgen Luhm Germany
Carmen Campos Spain
Masafumi Hasui Japan
S. M. Wolff United States View profile →
Citations per field, relative to Levine As
Levine As · 1×
Citations per year, relative to Levine As
Levine As · 1×

Countries citing papers authored by Levine As

Since Specialization
Citations

This map shows the geographic impact of Levine As's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levine As with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levine As more than expected).

Fields of papers citing papers by Levine As

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levine As. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levine As. The network helps show where Levine As may publish in the future.

Co-authorship network of co-authors of Levine As

This figure shows the co-authorship network connecting the top 25 collaborators of Levine As. A scholar is included among the top collaborators of Levine As based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levine As. Levine As is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
# Work Indexed citations
1
Limited diversity in the major histocompatibility complex class II loci of Syrian hamster DNA.
1
2
Damage inducible mutagenesis: recent insights into the activities of the Umu family of mutagenesis proteins.
51
3
Opioids in the regulation of food intake and energy expenditure.
22
4
Neuropeptidergic regulation of feeding.
9
5
Calcitonin as a regulator of gastric acid secretion.
6
6
Neuropeptidergic regulation of food intake. Introduction.
1
7
Interrelationships between calcitonin and other modulators of feeding behavior.
9
8
Antitumor effects of interferon and poly ICLC, and their possible utility as anti-neoplastic agents in man.
6
9
The kappa opioid receptor, ingestive behaviors and the obese mouse (ob/ob).
24
10
Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?
31
11
Combined modality treatment of Burkitt's lymphoma.
21
12
Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.
34
13
Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
4
14
Treatment of refractory acute leukemia with high-dose chemotherapy.
1
15
The utility of protected-environment regimens for the compromised host: a critical assessment.
23
16
Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.
236
17
Interdisciplinary session report. Germ-free biology and the patient with malignant disease: clinical and preclinical studies.
1
18
Management of infections in patients with leukemia and lymphoma: current concepts and experimental approaches.
119
19
Combination therapy with 6-mercaptopurine (NSC-755) and allopurinol (NSC-1390) during induction and maintenance of remission of acute leukemia in children.
6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026